Estimating the extent of vaccine-derived poliovirus infection.
BACKGROUND: Eight outbreaks of paralytic polio attributable to circulating vaccine-derived poliovirus (cVDPV) have highlighted the risks associated with oral poliovirus vaccine (OPV) use in areas of low vaccination coverage and poor hygiene. As the Polio Eradication Initiative enters its final stage...
Main Authors: | Alison Wringe, Paul E M Fine, Roland W Sutter, Olen M Kew |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2008-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2570794?pdf=render |
Similar Items
-
Preventing Vaccine-Derived Poliovirus Emergence during the Polio Endgame.
by: Margarita Pons-Salort, et al.
Published: (2016-07-01) -
Assessment of poliovirus antibody seroprevalence in high risk areas for vaccine derived poliovirus transmission in Madagascar
by: Richter Razafindratsimandresy, et al.
Published: (2018-03-01) -
Are Circulating Type 2 Vaccine-derived Polioviruses (VDPVs) Genetically Distinguishable from Immunodeficiency-associated VDPVs?
by: Kun Zhao, et al.
Published: (2017-01-01) -
Limited duration of vaccine poliovirus and other enterovirus excretion among human immunodeficiency virus infected children in Kenya
by: Tukei Peter, et al.
Published: (2009-08-01) -
Estimated Effect of Inactivated Poliovirus Vaccine Campaigns, Nigeria and Pakistan, January 2014–April 2016
by: George Shirreff, et al.
Published: (2017-02-01)